Herbal granules could cut heart risks after stent surgery

NCT ID NCT07616544

Not yet recruiting Disease control Sponsor: Liu Qiang Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding a Chinese herbal medicine called Qidan Xiaoke Granules to standard heart drugs can reduce major heart problems like heart attacks or repeat procedures in people who have had a stent placed. About 164 adults with coronary artery disease will take the granules twice daily for 12 weeks, and researchers will track their heart health for nearly a year. The goal is to see if this herbal approach offers extra protection beyond usual care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Qidan Xiaoke Granules (Chinese herbal compound)
What this could lead to: If successful, this could provide a new, low-cost add-on treatment to reduce heart attacks and hospital readmissions after stent surgery.
What could go wrong: This is a phase 3 trial, but it's relatively small (164 people) and tests a herbal compound, which may have variable quality or unknown interactions. The results may not apply to all heart patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY DISEASE MYOCARDIAL REVASCULARIZATION PERCUTANEOUS CORONARY INTERVENTION

More trials for these conditions

Other studies related to the condition(s) this trial covers.